Clinical Trials Logo

Filter by:
NCT ID: NCT00922350 Completed - Acute Asthma Clinical Trials

Heliox and Posture in Patients With Asthma

Start date: June 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to verify that nebulization with bronchodilators associated with heliox gas (helium + oxygen) and the posture of a leaning forward truck is effective in patients with an asthma attack.

NCT ID: NCT00922233 Completed - Healthy Clinical Trials

Pericoital Oral Contraception With Levonorgestrel

Start date: January 2010
Phase: Phase 3
Study type: Interventional

A prospective, open-label, single arm, multicenter study to evaluate efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel

NCT ID: NCT00921791 Completed - Hypertension Clinical Trials

Efficacy of Home Blood Pressure Monitoring (MONITOR Study)

MONITOR
Start date: April 2006
Phase: N/A
Study type: Interventional

High blood pressure is the main risk factor for cardiovascular disease worldwide,but its control rate is unsatisfactory. Home Blood Pressure Monitoring (HBPM) with automatic oscillometric devices and pharmaceutical care have been proposed as interventions to increase therapeutic compliance and to guide treatment decisions. The purpose of this study is to evaluate the effect of HBPM and of pharmaceutical care in blood pressure control measured through 24h ambulatory blood pressure monitoring (ABPM).

NCT ID: NCT00921557 Completed - HIV Infection Clinical Trials

Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents

Start date: November 2009
Phase: Phase 2
Study type: Interventional

HIV-infected children, youth, and adults have lower bone mineral density (BMD) than would be expected for HIV-uninfected people of similar age, weight and race. As the majority of perinatally HIV-infected U.S. children are entering or in adolescence, the potential for HIV-related impaired BMD during the adolescent peak of bone mass acquisition is of particular concern. The primary purpose of this study was to compare changes from pre-treatment levels of BMD of the lumbar spine after 24 and 48 weeks of alendronate treatment with placebo in HIV-infected children and adolescents.

NCT ID: NCT00920543 Completed - Asthma Clinical Trials

GSK BHR Study (Sont)

Start date: February 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study was to determine whether asthma control and reduced bronchial hyperresponsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS twice-daily or FP twice-daily in adult and adolescent subjects with persistent asthma

NCT ID: NCT00919854 Completed - Clinical trials for Human Immunodeficiency Virus 1

A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children

Start date: September 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics (what the body does to the medication), safety and antiviral activity to support dose recommendations by body weight of darunavir with low-dose ritonavir (DRV/rtv), in combination with other antiretroviral drugs (ARVs), in treatment-experienced Human immunodeficiency virus 1 (HIV 1) infected children.

NCT ID: NCT00917384 Completed - Gastric Cancer Clinical Trials

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Start date: August 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to gather information about the use of an investigational drug called Ramucirumab in adenocarcinomas of the stomach or gastroesophageal junction.

NCT ID: NCT00917163 Terminated - Clinical trials for Coronary Artery Disease

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Start date: July 2009
Phase: Phase 4
Study type: Interventional

The objective of Series III Run-In Trial is to compare the performance and efficacy of the Supralimus® sirolimus-eluting stent with the Xience V™ everolimus-eluting stent with respect to in-stent luminal late loss at 9 months as assessed by off-line QCA. Ninety percent power to reject the null hypothesis that the Supralimus® stent is inferior to Xience V™ in favor of the alternative hypothesis that the Supralimus® stent is not inferior to Xience V™.

NCT ID: NCT00916461 Completed - Clinical trials for First Episode Psychosis

Role of Minocycline in First Episode Psychosis

Start date: May 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether the addition of minocycline or placebo to treatment as usual (TAU): 1. prevents the accumulation of negative symptoms and intellectual decline following a first episode of non-affective psychosis; and 2. whether minocycline stabilizes the efficacy of antipsychotics.

NCT ID: NCT00916266 Completed - Epilepsy Clinical Trials

Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy

Start date: July 2008
Phase: Phase 1
Study type: Interventional

This research investigates the use of autologous bone marrow stem cells for the treatment of medically refractory temporal lobe epilepsy patients.